The framework starts from a clearly defined intended use (adults with suspected mTBI, GCS 13–15, sampling within ≤12 h) and a CT-based endpoint (acute intracranial lesion on head CT). Biomarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results